公司资料
Stryker 股价、新闻与催化剂
- 股票代码:
- SYK
- 交易所:
- NYSE
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
331.68 USD (-2.22%)
收盘价
最后更新: 2026年8月17日
112B USD
市值
股价为何变动
As of Aug 17, 2026, SYK closed down 2.22% at $331.68. No new same-company headline was identified in the current news window.
公司概览
Global MedTech Leader
Stryker is a global medical technology company offering products and services across MedSurg, Neurotechnology, and Orthopaedics. Its scale, global customer base, and product breadth make it one of the largest diversified medtech companies, with products that support surgical procedures, hospital workflows, orthopedic reconstruction, and neurotechnology care.
MedSurg and Neurotechnology Engine
MedSurg and Neurotechnology is Stryker's largest segment, generating $3.6 billion in second-quarter 2026 net sales. Growth was driven mainly by unit volume, showing continued demand across the company's procedural and hospital-facing technology portfolio.
Orthopaedics Franchise
Orthopaedics remains a major growth pillar, with $3.0 billion in second-quarter sales and strong organic growth. Stryker also reorganized elements of its orthopaedic instruments, neuro cranial, spine enabling technologies, and related portfolios to better align with internal reporting and business management.
Operational Resilience
The quarter also reflected recovery from a cyber incident reported earlier in 2026. Despite that disruption, Stryker delivered strong sales, EPS, and operating cash flow growth. This supports the company's positioning as a resilient medtech operator with a steady cadence of innovation and disciplined execution.
未来催化剂
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。